Loading clinical trials...
Loading clinical trials...
A Longitudinal Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis
Conditions
Interventions
MSDX Complex-1 Biomarker test
Locations
1
United States
Northwest NeuroSpecialists, PLLC
Tucson, Arizona, United States
Start Date
January 1, 2012
Primary Completion Date
July 1, 2012
Completion Date
July 1, 2012
Last Updated
September 2, 2020
NCT04047628
NCT04602390
NCT05978531
NCT04225312
NCT03536559
NCT05446285
Lead Sponsor
MSDx, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions